Boston Scientific Corp (NYSE:BSX)
| 48.23 Delayed Data As of 4:00pm ET |  +0.285 / +0.59%Today’s Change | 34.98 Today|||52-Week Range 49.22 | +4.23% Year-to-Date |
Latest BSX News | Press Releases
| Here's Why You Should Retain Boston Scientific (BSX) Now Mar 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 47.94 |
| Today’s open | 47.90 |
| Day’s range | 47.52 - 48.30 |
| Volume | 10,069,269 |
| Average volume (3 months) | 6,914,501 |
| Market cap | $69.3B |
Data as of 4:00pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -35.19% |
| Earnings growth (this year) | +11.60% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +6.68% |
| P/E ratio | 107.2 |
| Price/Sales | 5.25 |
| Price/Book | 3.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +4.08 | +1.73% |
| DXCMDexcom Inc | -0.40 | -0.35% |
| ZBHZimmer Biomet Holdin... | +1.09 | +0.87% |
| WSTWest Pharmaceutical ... | +2.90 | +0.87% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | April 26, 2023 |
| EPS forecast (this quarter) | $0.43 |
| Annual revenue (last year) | $12.7B |
| Annual profit (last year) | $698.0M |
| Net profit margin | 5.50% |
Profile
Sector Distribution Services |
Industry Medical Distributors |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
